Patent · US Active

Administration of oral methyldopa

US11013707B2 · kind B2 · utility

0Cited by
23References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 23, 2018
Grant dateMay 25, 2021
Priority date—
Expiry dateMar 23, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/1617
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of administering methyldopa to a subject in a fasting state to increase bioavailability of the methyldopa.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.